Gregory Berk - Pres. of R&D, CMO at GT Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. of R&D, CMO
Stock Symbol
GTBP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gregory Berk since 8/27/2023

Holdings reported by Gregory Berk for GT Biopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 278K $79.8K $0.29 Feb 16, 2021 Direct
Option to purchase Common Stock 50K Jul 15, 2022 Direct Common Stock

Transactions reported by Gregory Berk for GT Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.